Publikasjoner
Vitenskapelig artikkel
- Liv Cathrine Heggebø; Taran Annette Paulsen Hellebust; Thomas Henry et al. (2026). Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries. (ekstern lenke)
- Bente Sandvei Skeie; Alexander R. Craven; Eli Renate Grüner et al. (2026). Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. (ekstern lenke)
- Liv Cathrine Heggebø; Tor-Christian Aase Johannessen; Henriette Magelssen et al. (2026). Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy. (ekstern lenke)
- Saruar Alam; Bharath Halandur; PierGianLuca Porta Mana et al. (2022). Brain Tumor Segmentation from Multiparametric MRI Using a Multi-encoder U-Net Architecture. (ekstern lenke)
- Mikael Eriksson; Peter Reichardt; H. Joensuu et al. (2021). Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST). (ekstern lenke)
- Dorota Goplen; Sébastien Bougnaud; Uros Rajcevic et al. (2010). alpha B-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells. (ekstern lenke)
- Tiziana Piepoli; Cemile Jakupoglu; Wenli Gu et al. (2006). Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. (ekstern lenke)
- Kirsten Sundby Hall; Øyvind Bruland; Bodil Bjerkehagen et al. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX). (ekstern lenke)
- Karina Christensen; Charlotte Aaberg-Jessen; Claus Andersen et al. (2010). Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium. (ekstern lenke)
- Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats. (ekstern lenke)
- Peter Csaba Huszthy; Dorota Goplen; Frits Alan Thorsen et al. (2008). Oncolytic herpes simplex virus type-1 therapy in a highly infiltrative animal model of human glioblastoma. (ekstern lenke)
- Mohummad Aminur Rahman; Jorunn Brekke; Victoria Smith Arnesen et al. (2020). Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. (ekstern lenke)
- Heikki Joensuu; Annette Reichardt; Mikael Eriksson et al. (2024). Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. (ekstern lenke)
- Hanne Kristin Blakstad; Jorunn Brekke; Mohummad Aminur Rahman et al. (2023). Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions. (ekstern lenke)
- Synnøve Yndestad; Hans Kristian Haugland; Dorota Katarzyna Pazdyk Goplen et al. (2024). Germline variants in patients diagnosed with pediatric soft tissue sarcoma. (ekstern lenke)
- Peter Csaba Huszthy; Heike Immervoll; Jian Wang et al. (2010). Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment. (ekstern lenke)
- Marianne Hjellvik Hannisdal; Dorota Goplen; Saruar Alam et al. (2023). Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI. (ekstern lenke)
- Mohummad Aminur Rahman; Agnete Engelsen; Shahin Sarowar et al. (2022). Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway. (ekstern lenke)
- Mohummad Aminur Rahman; Andrea Gras Navarro; Jorunn Brekke et al. (2019). Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival. (ekstern lenke)
- Dorota Goplen; Jian Wang; Per Øyvind Enger et al. (2006). Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. (ekstern lenke)
- Inger Anne Netland; Hilde Elise Førde-Tislevoll; Linda Sleire et al. (2016). Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models. (ekstern lenke)
- Hans Olav Ueland; Svein Arthur Hønsi Jensen; Eyvind Rødahl et al. (2026). Outcomes in Norwegian Cohort with Malignant Orbital Tumours. (ekstern lenke)
Konferanseabstrakt
- Hilde Elise Sundøy Førde; Inger Anne Netland; Linda Sleire et al. (2013). COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. (ekstern lenke)
- Dorota Goplen; Jian Wang; Berit Bølge Tysnes et al. (2005). Bacitracin inhibits glioma cell migration and invasion in vitro. (ekstern lenke)
Konferanseforedrag
- Sidsel Marit Bragstad; Øystein Vesterli Tveiten; MAZIAR BEHBAHANI et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Sidsel Marit Bragstad; Øystein Vesterli Tveiten; MAZIAR BEHBAHANI et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Bente Sandvei Skeie; Sidsel Marit Bragstad; Dorota Katarzyna Pazdyk Goplen et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Per Øyvind Enger; Sidsel Marit Bragstad; Jan Ingemann Heggdal et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)
- Per Øyvind Enger; Sidsel Marit Bragstad; Øystein Vesterli Tveiten et al. (2022). Phase I trial of Sulfasalazine combined with Stereotactic Radiosurgery for recurrent Glioblastoma: Study protocol for NCT04205357. (ekstern lenke)